Literature DB >> 23688937

Diagnosis and management of life-threatening cardiac malformations in the newborn.

Mats Mellander1.   

Abstract

Approximately 1-2 per 1000 newborn babies have a cardiac defect that is potentially life-threatening usually because either the systemic or the pulmonary blood flow is dependent on a patent ductus arteriosus. A significant proportion of newborns with such cardiac defects are being discharged from well-baby nurseries without a diagnosis and therefore risk circulatory collapse and death. This risk is greatest for defects with duct-dependent systemic circulation, notably aortic arch obstruction, but is also significant in transposition of the great arteries, for example. The solution to this problem, apart from improving prenatal detection rates, is to introduce effective neonatal screening including routine pulse oximetry.
Copyright © 2013 The Author. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Aortic coarctation; Congenital heart defects; Neonatal screening; Newborn; Pulse oximetry screening; Transposition of the great vessels

Mesh:

Year:  2013        PMID: 23688937     DOI: 10.1016/j.siny.2013.04.007

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  5 in total

1.  Echocardiographic Evaluation in Neonates with Heart Murmurs.

Authors:  Shokoufeh Ahmadipour; Azam Mohsenzadeh; Maryam Soleimaninejad
Journal:  J Pediatr Intensive Care       Date:  2017-12-18

2.  Toward Improving the Fetal Diagnosis of Coarctation of the Aorta.

Authors:  Meaghan Beattie; Shabnam Peyvandi; Suguna Ganesan; Anita Moon-Grady
Journal:  Pediatr Cardiol       Date:  2016-11-25       Impact factor: 1.655

3.  Critical Cardiopulmonary Event Series: Four Simulations for Pediatric ICU Fellows, Critical Care Nurses, and Pediatric Residents.

Authors:  Charles Mac Bergman; Joy Howell
Journal:  MedEdPORTAL       Date:  2020-03-20

4.  Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.

Authors:  Aikaterini K Seliniotaki; Anna-Bettina Haidich; Maria Lithoxopoulou; Helen Gika; Eleftheria Boutou; Christina Virgiliou; Martha Nikolaidou; Aristides Dokoumetzidis; Nikolaos Raikos; Elisavet Diamanti; Nikolaos Ziakas; Asimina Mataftsi
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.279

5.  Transcatheter cardiac interventions in neonates with congenital heart disease: A single centre experience.

Authors:  Asli Nuriye Melekoglu; Osman Baspinar
Journal:  J Int Med Res       Date:  2018-10-30       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.